EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Biological Evaluation of 5,8-Dimethyl Shikonin Oximes as SARS-CoV-2 Mpro Inhibitors

Jiahua Cui iD, Shouyan Xiang iD, Qijing Zhang, Shangqing Xiao, Gaoyang Yuan, Chenwu Liu, Shaoshun Li

Molecules · 2025

DOI: 10.3390/molecules30061321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Jiahua Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Gannan Medical University, Ganzhou 341000, China. Hauptthemen laut MEDLINE: Naphthoquinones, Oximes, SARS-CoV-2, Coronavirus 3C Proteases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have designed, synthesized, and characterized a small library of shikonin derivatives and demonstrated their inhibitory activity against the main protease, Mpro, of SARS-CoV-2. One analog, 5,8-dimethyl shikonin oxime (15), exhibited the highest activity against SARS-CoV-2 Mpro with an IC50 value of 12.53 ± 3.59 μM. It exhibited much less toxicity as compared with the parent compound, shikonin, in both in vitro and in vivo models. Structure–activity relationship analysis indicated that the oxime moieties on the naphthalene ring and the functional groups attached to the oxygen atom on the side chain play a pivotal role in enzymatic inhibitory activity. Molecular docking results implied that the inhibitor 15 is perfectly settled in the core of the substrate-binding pocket of Mpro by possibly interacting with three catalytic residues, His41, Cys145, and Met165. Overall, the shikonin oxime derivative 15 deserves further investigation as an antiviral agent against SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaphthoquinonesOximesSARS-CoV-2Coronavirus 3C ProteasesAntiviral AgentsMolecular Docking SimulationStructure-Activity RelationshipDrug DesignHumansAnimalsCOVID-19 Drug TreatmentCOVID-19Vero Cells

Stichwörter der Autor:innen

COVID-19SARS-CoV-2 Mprodimethyl shikonin oximesinhibitorsshikonin

Substanzen

NaphthoquinonesOximesCoronavirus 3C ProteasesshikoninAntiviral Agents

Autor:innen und Institutionen

  • School of Pharmacy, Gannan Medical University, Ganzhou 341000, China.
  • Jiangxi Province Key Laboratory of Pharmacology of Traditional Chinese Medicine, Gannan Medical University, Ganzhou 341000, China.
  • School of Chemistry and Chemical Engineering, Shanghai Jiaotong University, Shanghai 200240, China.
  • School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China.

ORCID-Profile: Jiahua Cui, Shouyan Xiang

Förderung

  • Medical and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University

Zitieren

APA

Cui, J., Xiang, S., Zhang, Q., Xiao, S., Yuan, G., Liu, C., & Li, S. (2025). Design, Synthesis, and Biological Evaluation of 5,8-Dimethyl Shikonin Oximes as SARS-CoV-2 Mpro Inhibitors. Molecules. https://doi.org/10.3390/molecules30061321

Vancouver

Cui J, Xiang S, Zhang Q, Xiao S, Yuan G, Liu C, et al. Design, Synthesis, and Biological Evaluation of 5,8-Dimethyl Shikonin Oximes as SARS-CoV-2 Mpro Inhibitors. Molecules. 2025. doi:10.3390/molecules30061321

BibTeX
@article{Cui2025,
  author = {Cui, Jiahua and Xiang, Shouyan and Zhang, Qijing and Xiao, Shangqing and Yuan, Gaoyang and Liu, Chenwu and Li, Shaoshun},
  title = {Design, Synthesis, and Biological Evaluation of 5,8-Dimethyl Shikonin Oximes as SARS-CoV-2 Mpro Inhibitors},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30061321}
}
Kostenlos starten →